Jean-Pierre Goullé is a toxicologist, member of the national academies of pharmacy and medicine.
Cannabis for medical use, which benefits from the provisions of temporary authorization for use and which is being tested as part of the experiment scheduled for 2021, should not be confused with so-called “recreational” cannabis, which presents a risk of toxicity. recognized for health, particularly in adolescents.
Read also:
Tobacco, cannabis, drinking ... and screens: in 20 years, the change in teenage consumption
France is the largest consumer in Europe and drugs, which circulate from the age of 12, have been experienced by half of the final year students.
France is also the country in Europe which consumes cannabis in the most concentrated form, in a proportion of 70% in the form of resin alone or associated with the herb, and only up to 30% in the form of herb !
This puts us well ahead in terms of dangerousness ahead of the Netherlands, Italy and even further ahead of the United Kingdom ...
It should be noted that this cannabis resin has nothing left
This article is for subscribers only.
You have 82% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
I ENJOY IT
Already subscribed?
Log in
/cloudfront-eu-central-1.images.arcpublishing.com/prisa/MXP5VLYEOJEP7C5YRYNRRHMHOA.jpg)
